In the first half-year of 2022, the regions procured hospital medicines via Amgros costing more than DKK 4.1 billion. Expenditure on pharmaceuticals thus increased by more than DKK 34 million compared with the same period last year, corresponding to a small percentage increase of 0.8%. This is described in Amgros’ Market Surveillance report for Q2 2022 (in Danish).
The volume procured increased by a slightly smaller percentage than procurements in terms of DKK. This means that, in the first half-year, the regions procured medicines that are slightly more expensive per DDD (defined daily dosage) than in the first half-year of 2021.
Amgros obtained discounts through tendering procedures or negotiations of 46% for the first half of 2022. This means that the prices hospital pharmacies pay were 46% less than the list prices (the prices paid by private pharmacies). This is an increase of about 3 percentage points compared with the first half of 2021.
Read more in the Market Surveillance report for Q2 2022 (in Danish)